Torrent Pharmaceuticals company profile

TORNTPHARM · NSE · INR

Compare Torrent Pharmaceuticals
₹4,689.50Change from previous close: +1.70%Absolute change: +₹78.50

Close · November 20, 2026

Company profile

Torrent Pharmaceuticals has 18,258 employees and is headquartered in Ahmedabad, India.

Shelcal, Tedibar, Unienzyme, ProZuca and Ahaglow are among the brands under which the company sells its products. Torrent Pharmaceuticals develops, makes, markets and distributes branded and generic medicines, along with vitamin, mineral and nutrient supplements. Its range spans diabetes, cardiovascular care, the central nervous system, oncology, gastrointestinal, urology and dermatology treatments, among others. The company also offers contract manufacturing services and sells in India, the United States, Brazil, Germany, Malta and other international markets.

In the fiscal year ended March 2026, Torrent Pharmaceuticals reported revenue of INR 139.8 billion, up 21.4% from the previous year, and net profit of INR 21.6 billion. The company employed 18,258 people. It was founded in 1959 and is headquartered in Ahmedabad, India. Its shares also trade on the BSE.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
India
Headquarters
Avirat, Thaltej Shilaj Road, 380059, Ahmedabad
Employees
18,258
Chief executive
Aman Mehta
Founded
1959
Fiscal year
April - March
Listing
TORNTPHARM · NSE
Currency
INR
ISIN
INE685A01028

Torrent Pharmaceuticals and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Torrent PharmaceuticalsTORNTPHARMIndia$19.25B18,25822.2%79.2
Shionogi4507Japan$16.75B6,22331.6%11.2
PharmaEssentia6446Taiwan$15.94B13138.4%74.1
Hansoh Pharmaceutical Group3692Hong Kong SAR China$23.77B9,64337.3%25.0
Yunnan Baiyao Group000538China$15.07B9,28611.2%19.4
Laurus LabsLAURUSLABSIndia$14.13B7,05924.1%97.8

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Torrent Pharmaceuticals with its competitors